Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
ACR Convergence
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.
Simple Tasks
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Rheumatology Research Foundation
The Foundation is the largest private funding source for rheumatology research and training in the U.S.